ClinicalTrials.Veeva

Menu

4Kscore Using Serum Stored Uncentrifuged

OPKO Health logo

OPKO Health

Status

Completed

Conditions

Prostate Cancer

Treatments

Diagnostic Test: Measurement of four prostate-specific kallikreins for the 4Kscore Test when serum stored uncentrifuged

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of the study is to evaluate whether storage of serum uncentrifuged is an allowable preanalytical procedure

Enrollment

64 patients

Sex

Male

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men capable of donating five 5 mL tubes of whole blood
  • 40 to 80 years old
  • No prior diagnosis of prostate cancer; prior negative prostate biopsy included
  • Total PSA (tPSA) value measured within last year to be: at 1.5 ng/mL to 4 ng/mL, 4.1 ng/mL to 10 ng/mL and 10 ng/mL and above

Exclusion criteria

  • In the previous 96 hours (4 days), underwent a digital rectal exam
  • Any invasive urologic procedure in the 6 months prior to study participation
  • Underwent any procedure to treat symptomatic benign prostatic hyperplasia in the last 6 months
  • Radical prostatectomy since tPSA measurement
  • Received within the previous 6 months 5-alpha reductase inhibitor (5-ARI) therapy such as Avodart (dutasteride) or Proscar (finasteride)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems